# Postoperative Chemoradiation or Chemotherapy After Preoperative Chemotherapy for Gastric Cancers

> **NCT03515941** · EARLY_PHASE1 · TERMINATED · sponsor: **Tannaz Armaghany** · enrollment: 6 (actual)

## Conditions studied

- Gastrointestinal Cancer

## Interventions

- **DRUG:** Oxaliplatin
- **DRUG:** Capecitabine
- **DRUG:** Leucovorin
- **DRUG:** 5-fluorouracil
- **RADIATION:** radiation

## Key facts

- **NCT ID:** NCT03515941
- **Lead sponsor:** Tannaz Armaghany
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-06-22
- **Primary completion:** 2020-03-17
- **Final completion:** 2020-06-18
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** The PI has decided to close the study due to the outdated study design.
- **Last updated:** 2020-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03515941

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03515941, "Postoperative Chemoradiation or Chemotherapy After Preoperative Chemotherapy for Gastric Cancers". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03515941. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*